An immunosuppressant is a medicine that reduces activity in the immune system. Immunosuppressants are used when the immune system is causing harm, when inflammation needs to be controlled, or when the body might reject a transplanted organ.
These medicines are important in transplant medicine, autoimmune disease, inflammatory bowel disease, dermatology, rheumatology, nephrology, respiratory medicine, and some neurological conditions. They can be highly effective, but they require careful monitoring because reduced immune activity can increase infection risk and affect other organs.
How They Work
The immune system is made of cells, antibodies, and signalling molecules that protect against infection and abnormal cells. Immunosuppressants interfere with selected parts of that response.
Different medicines act in different ways:
- Some reduce broad inflammation.
- Some slow immune-cell growth.
- Some reduce T-cell activation.
- Some reduce B-cell activity or antibody production.
- Some block specific cytokines or inflammatory pathways.
- Some target immune cells directly through biological antibodies.
Modern treatment often aims for targeted immune control rather than shutting the entire immune system down.
Uses
Common uses include:
- Preventing rejection after kidney, liver, heart, lung, or other organ transplantation.
- Treating autoimmune disorders such as rheumatoid arthritis, lupus, vasculitis, autoimmune kidney disease, and autoimmune bowel disease.
- Treating inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
- Treating severe psoriasis, eczema, uveitis, or other inflammatory eye and skin disease.
- Managing some neurological inflammatory diseases.
- Preventing or treating graft-versus-host disease after some stem-cell transplants.
The choice of medicine depends on the disease, severity, other health conditions, pregnancy plans, infection history, previous treatment response, and monitoring requirements.
Main Classes
Major classes include:
- Corticosteroids: prednisolone, methylprednisolone, and related medicines. These act quickly and are often used for flares, but long-term use can cause significant side effects.
- Calcineurin inhibitors: tacrolimus and ciclosporin. These are central in many transplant regimens and some autoimmune conditions.
- Antimetabolites: azathioprine, methotrexate, mycophenolate mofetil, and similar medicines. These affect immune-cell growth and immune activity.
- mTOR inhibitors: sirolimus and everolimus, used in some transplant and specialist settings.
- Biological medicines: monoclonal antibodies or receptor blockers that target specific immune cells or inflammatory signals.
- Janus kinase inhibitors: targeted small-molecule medicines used in selected inflammatory conditions.
Some medicines are used at different doses for different diseases. A medicine used after a transplant may have a different risk profile from the same medicine used for a milder inflammatory condition.
Monitoring
Monitoring is a major part of immunosuppressant treatment. Depending on the medicine, clinicians may check:
- Full blood count.
- Kidney and liver function.
- Drug levels in the blood.
- Blood pressure.
- Blood sugar.
- Infection screening, such as tuberculosis or hepatitis testing.
- Vaccination status.
- Pregnancy risks and contraception where relevant.
- Skin checks or cancer risk in long-term treatment.
NHS Blood and Transplant notes that kidney transplant recipients usually need immunosuppressant medicines to reduce the risk of rejection, and that some will be needed for the lifetime of the transplant.
Side Effects and Risks
Risks differ by medicine, dose, and patient. Common concerns include:
- Increased risk of infection.
- Slower recovery from some infections.
- Low white blood cell counts or other blood-count changes.
- Liver or kidney effects.
- High blood pressure.
- Raised blood sugar.
- Stomach irritation, nausea, or diarrhoea.
- Tremor with some transplant medicines.
- Bone thinning, weight gain, mood change, or skin thinning with longer-term corticosteroids.
- Increased risk of some cancers with long-term or intensive immune suppression.
The risk is not the same for every person. Some people use low-dose treatment for years with stable monitoring, while others need intensive combinations after transplantation or during severe disease.
Infection and Vaccination
Because immunosuppressants reduce immune activity, infection prevention is often part of care. Patients may be advised about vaccinations, avoiding live vaccines during some treatments, early reporting of fever or infection symptoms, and temporary medicine changes during serious infection.
Vaccination planning is usually done before treatment starts where possible. The exact advice depends on the medicine and the person's condition.
Stopping or Changing Treatment
Stopping an immunosuppressant suddenly can be dangerous in some circumstances. It may trigger transplant rejection, a severe disease flare, adrenal problems after long-term steroid use, or loss of disease control.
Changes are usually made by reducing dose, switching medicine, or adding another medicine under specialist supervision.
See Also
References
Discussion log
Use comments for sourcing notes, corrections, and disputed details.
No comments yet.